# M/I Homes, Inc.: financial statements, quarterly

MHO · NYSE · CIK 799292 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mho.md) · [Financials](/companies/mho/financials.md) · [Filings](/companies/mho/filings.md) · [Insiders](/companies/mho/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mho/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [973 d](/filings/0000799292-26-000006.md) | [1,047](/filings/0000799292-25-000033.md) | [1,110](/filings/0000799292-25-000059.md) | [1,143](/filings/0000799292-25-000077.md) | [1,205 d](/filings/0000799292-26-000006.md) | [976](/filings/0000799292-26-000017.md) | [1,163](/filings/0000799292-26-000028.md) | [1,132](/filings/0000799292-26-000033.md) | [1,147 d](/filings/0000799292-26-000006.md) | [921](/filings/0000799292-26-000017.md) | [1,063](/filings/0000799292-26-000028.md) | [1,076](/filings/0000799292-26-000033.md) |
| Cost of revenue | $m | [728 d](/filings/0000799292-26-000006.md) | [763](/filings/0000799292-25-000033.md) | [801](/filings/0000799292-25-000059.md) | [833](/filings/0000799292-25-000077.md) | [908 d](/filings/0000799292-26-000006.md) | [723](/filings/0000799292-26-000017.md) | [876](/filings/0000799292-26-000028.md) | [862](/filings/0000799292-26-000033.md) | [940 d](/filings/0000799292-26-000006.md) | [718](/filings/0000799292-26-000017.md) | [828](/filings/0000799292-26-000028.md) | [852](/filings/0000799292-26-000033.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [130 d](/filings/0000799292-26-000006.md) | [173](/filings/0000799292-25-000033.md) | [187](/filings/0000799292-25-000059.md) | [182](/filings/0000799292-25-000077.md) | [164 d](/filings/0000799292-26-000006.md) | [141](/filings/0000799292-26-000017.md) | [156](/filings/0000799292-26-000028.md) | [135](/filings/0000799292-26-000033.md) | [74.6 d](/filings/0000799292-26-000006.md) | [86.1](/filings/0000799292-26-000017.md) | [101](/filings/0000799292-26-000028.md) | [83.3](/filings/0000799292-26-000033.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [32.7 d](/filings/0000799292-26-000006.md) | [42.2](/filings/0000799292-25-000033.md) | [47.4](/filings/0000799292-25-000059.md) | [43.2](/filings/0000799292-25-000077.md) | [37.1 d](/filings/0000799292-26-000006.md) | [34.9](/filings/0000799292-26-000017.md) | [38.9](/filings/0000799292-26-000028.md) | [33.3](/filings/0000799292-26-000033.md) | [16.6 d](/filings/0000799292-26-000006.md) | [21.3](/filings/0000799292-26-000017.md) | [25.5](/filings/0000799292-26-000028.md) | [20.3](/filings/0000799292-26-000033.md) |
| Net income | $m | [105 d](/filings/0000799292-26-000006.md) | [138](/filings/0000799292-25-000033.md) | [147](/filings/0000799292-25-000059.md) | [145](/filings/0000799292-25-000077.md) | [133 d](/filings/0000799292-26-000006.md) | [111](/filings/0000799292-26-000017.md) | [121](/filings/0000799292-26-000028.md) | [106](/filings/0000799292-26-000033.md) | [64.0 d](/filings/0000799292-26-000006.md) | [67.8](/filings/0000799292-26-000017.md) | [79.1](/filings/0000799292-26-000028.md) | [66.6](/filings/0000799292-26-000033.md) |
| Diluted EPS | $ per share | not reported | [4.78](/filings/0000799292-25-000033.md) | [5.12](/filings/0000799292-25-000059.md) | [5.10](/filings/0000799292-25-000077.md) | not reported | [3.98](/filings/0000799292-26-000017.md) | [4.42](/filings/0000799292-26-000028.md) | [3.92](/filings/0000799292-26-000033.md) | not reported | [2.55](/filings/0000799292-26-000017.md) | [3.02](/filings/0000799292-26-000028.md) | [2.56](/filings/0000799292-26-000033.md) |
| Basic EPS | $ per share | not reported | [4.92](/filings/0000799292-25-000033.md) | [5.26](/filings/0000799292-25-000059.md) | [5.26](/filings/0000799292-25-000077.md) | not reported | [4.07](/filings/0000799292-26-000017.md) | [4.52](/filings/0000799292-26-000028.md) | [4.01](/filings/0000799292-26-000033.md) | not reported | [2.61](/filings/0000799292-26-000017.md) | [3.08](/filings/0000799292-26-000028.md) | [2.62](/filings/0000799292-26-000033.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [4,022](/filings/0000799292-25-000018.md) | [4,212](/filings/0000799292-24-000039.md) | [4,340](/filings/0000799292-24-000070.md) | [4,460](/filings/0000799292-24-000092.md) | [4,550](/filings/0000799292-26-000006.md) | [4,585](/filings/0000799292-25-000033.md) | [4,740](/filings/0000799292-25-000059.md) | [4,770](/filings/0000799292-25-000077.md) | [4,777](/filings/0000799292-26-000033.md) | [4,788](/filings/0000799292-26-000017.md) | [4,856](/filings/0000799292-26-000028.md) | [4,860](/filings/0000799292-26-000033.md) |
| Total liabilities | $m | [1,506](/filings/0000799292-25-000018.md) | [1,573](/filings/0000799292-24-000039.md) | [1,599](/filings/0000799292-24-000070.md) | [1,615](/filings/0000799292-24-000092.md) | [1,610](/filings/0000799292-26-000006.md) | [1,579](/filings/0000799292-25-000033.md) | [1,658](/filings/0000799292-25-000059.md) | [1,620](/filings/0000799292-25-000077.md) | [1,611](/filings/0000799292-26-000033.md) | [1,596](/filings/0000799292-26-000017.md) | [1,629](/filings/0000799292-26-000028.md) | [1,608](/filings/0000799292-26-000033.md) |
| Shareholders' equity | $m | [2,517](/filings/0000799292-25-000018.md) | [2,639](/filings/0000799292-24-000039.md) | [2,741](/filings/0000799292-24-000070.md) | [2,845](/filings/0000799292-24-000092.md) | [2,940](/filings/0000799292-26-000006.md) | [3,006](/filings/0000799292-25-000033.md) | [3,082](/filings/0000799292-25-000059.md) | [3,149](/filings/0000799292-25-000077.md) | [3,166](/filings/0000799292-26-000033.md) | [3,192](/filings/0000799292-26-000017.md) | [3,227](/filings/0000799292-26-000028.md) | [3,253](/filings/0000799292-26-000033.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [54.9 d](/filings/0000799292-26-000006.md) | [116](/filings/0000799292-25-000033.md) | [27.5 d](/filings/0000799292-25-000059.md) | [(67.9) d](/filings/0000799292-25-000077.md) | [104 d](/filings/0000799292-26-000006.md) | [64.9](/filings/0000799292-26-000017.md) | [37.8 d](/filings/0000799292-26-000028.md) | [43.4 d](/filings/0000799292-26-000033.md) | [(8.7) d](/filings/0000799292-26-000006.md) | [136](/filings/0000799292-26-000017.md) | [36.8 d](/filings/0000799292-26-000028.md) | [(13.3) d](/filings/0000799292-26-000033.md) |
| Capital expenditure | $m | [1.2 d](/filings/0000799292-26-000006.md) | [0.3](/filings/0000799292-25-000033.md) | [5.5 d](/filings/0000799292-25-000059.md) | [0.6 d](/filings/0000799292-25-000077.md) | [2.1 d](/filings/0000799292-26-000006.md) | [1.3](/filings/0000799292-26-000017.md) | [2.6 d](/filings/0000799292-26-000028.md) | [1.4 d](/filings/0000799292-26-000033.md) | [4.3 d](/filings/0000799292-26-000006.md) | [0.2](/filings/0000799292-26-000017.md) | [5.4 d](/filings/0000799292-26-000028.md) | [3.6 d](/filings/0000799292-26-000033.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [25.1 d](/filings/0000799292-26-000006.md) | [25.3](/filings/0000799292-25-000033.md) | [50.3 d](/filings/0000799292-25-000059.md) | [50.2 d](/filings/0000799292-25-000077.md) | [51.1 d](/filings/0000799292-26-000006.md) | [50.1](/filings/0000799292-26-000017.md) | [50.1 d](/filings/0000799292-26-000028.md) | [50.2 d](/filings/0000799292-26-000033.md) | [51.7 d](/filings/0000799292-26-000006.md) | [50.1](/filings/0000799292-26-000017.md) | [50.1 d](/filings/0000799292-26-000028.md) | [50.1 d](/filings/0000799292-26-000033.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [28.3](/filings/0000799292-24-000039.md) | [28.6](/filings/0000799292-24-000070.md) | [28.8](/filings/0000799292-24-000092.md) | [28.9](/filings/0000799292-25-000033.md) | [28.7](/filings/0000799292-25-000059.md) | [28.5](/filings/0000799292-25-000077.md) | [27.9](/filings/0000799292-26-000017.md) | [27.4](/filings/0000799292-26-000028.md) | [27.2](/filings/0000799292-26-000033.md) | [26.6](/filings/0000799292-26-000017.md) | [26.2](/filings/0000799292-26-000028.md) | [25.9](/filings/0000799292-26-000033.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 25,031,231 at 2026-10-21, from the cover of the [10-Q filed 2026-10-23](/filings/0000799292-26-000033.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.